Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

NCT00363415 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

908

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: pemetrexed
DRUG: etoposide
DRUG: carboplatin

Sponsor

Eli Lilly and Company